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CORRECTION Open Access
Correction: Cerebral ischemia induces
microvascular pro-inflammatory cytokine
expression via the MEK/ERK pathway
Aida Maddahi
1,2, Lars Edvinsson
1,2*
We wish to clarify in results page 4, line 22 of our study
[1]; that the information on infarct volume and neurology
score after MCAO was taken from our previous study [2].
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